| Eli Lilly (Suisse) SA - Mounjaro 12.5 mg, solution pour injection en stylo pré-rempli |
| 68726 | | 05 | | Mounjaro 12.5 mg | | solution pour injection en stylo pré-rempli | | A10BX16 | | | | 02.11.2022 | | |
|
| Composition |
| tirzepatidum 12.5 mg, dinatrii phosphas heptahydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp., natrium 1.8 - 1.9 mg. |
| Packungsbestandteile |
| solution pour injection en stylo pré-rempli | | | | | | | | Active Agent | Dose |
|---|
| Tirzepatidum | 12.5mg / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Tirzepatidum | 12.5 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Disodium Phosphate Heptahydrate | | Sodium Chloride | | Sodium Hydroxide |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 4 | 355.71 | 388.40 | B | SL | No |
|
